Sepragen.com

Home | Contact Us 


Online Catalog


View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at sales@sepragen.com.



How Can We Help You?
Click here to contact us!

 



All news items and press releases prior to 2008 are listed here. (Return to main News page.)

Press Release Archives

May 17, 2006: Sepragen Announces Intent to Acquire Assets of Cytobiologics and Pursue Development of Integrated Cell Culture/Purification System

May 15, 2006: Sepragen Announces Profibility and Doubling of Revenues for 2005; Announces New Financing Round

May 15, 2006: Sepragen Announces Biomedical Resources International, Inc. as New East Coast Representative

February 22, 2005: Sepragen Signs Supply Agreement with Pall Corporation for Bench-Top Chromatography Systems

December 9, 2002: Sepragen Reports Substantial Revenue Increase

June 5, 2002: Sepragen Announces the Launch of the QuantaSep 5000

July 10, 2001: Sepragen Plans Strategic Restructuring

January 15, 2001: Sepragen Announces Increased Bookings

January 12, 2001: Sepragen Relocates to New Facility

December 19, 2000: Sepragen Announces Senior Management Addition

November 27, 2000: Sepragen Announces Senior Management Addition

November 22, 2000: Sepragen Corporation Announces Third Quarter Results

November 16, 2000: Sepragen Announces Letter of Intent to Acquire Assets of Process Equipment, Inc.

August 9, 2000: Wedge - A Column Designed for Scale-Up Studies

July 11, 2000: Sepragen Corporation Announces The Addition of K. Charles Janac To Its Board of Directors.

April 5, 2000: Sepragen Corporation Completes $2.5 Million Private Stock Sale

March 27, 2000: Sepragen Corporation Announces Expiration Of Its Class A and Class B Redeemable Warrants

March 22, 2000: Sepragen Corporation Launches Quantasep 'BioTech Software' For Microsoft Windows NT

March 6, 2000: Sepragen Corporation Announces The Addition Of A “Techno-Business” Advisory Board

February 17, 2000: Sepragen Corporation Receives ‘Notice Of Allowance’ For Two Additional Patents

February 15, 2000: Sepragen Corporation Announces New Distributors For Its BioTech Business In Europe

February 7, 2000: Sepragen Corporation Announces The Addition Of Joseph R. Mallon, Jr. To Its Board Of Directors

September 24, 1999: Sepragen Corporation Announces Management Addition To Focus On Dairy Opportunities

September 21, 1999: Sepragen Corporation Announces Successful Commissioning Of Sepralac® Plant At Carbery Food Ingredients

September 3, 1999: Sepragen Corporation Announces Q2 Results; Losses Narrow

August 6, 1999: Sepragen Announces Successful Commercial Launch of Its Sepralac® Dairy Process at Anchor Products

July 23, 1999: Sepragen Announces Fiscal 1998 Year End Results and Fiscal 1999 First Quarter Results

March 4, 1999: Sepragen Converts Debt to Equity and Removes Lien on Patents

November 11, 1998: Sepragen Signs Pacific Rim Distributorship with YMC

October 15, 1998: Sepragen Announces Agreement With Carbery Food Ingredients

September 15, 1998: Sepragen Corporation Establishes Internet Presence

August 25, 1998: Sepragen Signs Major License Agreement With Dairy Leader, Anchor Products Ltd.

May 31, 1998: Sepragen Grants a Temporary License to Tropicana Products, Inc.

April 29, 1998: Sepragen Signs North American Distributorship with Bodman Industries

April 23, 1998: Sepragen Signs a Letter of Intent With GoldTech Ingredients Group

News Archives

May 11, 1999: Sepragen Corporation CEO discusses move from product development to commercialization, The Wall Street Transcript

March 1, 1999: Sepragen takes cutting edge off biotech products, American City Business Journal


Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2017 Sepragen Corporation. All rights reserved. (510) 475-0650